These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7515741)

  • 1. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased numbers of CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Yabe H; Yabe M; Kato S; Kimura M; Iwaki K
    Bone Marrow Transplant; 1990 May; 5(5):295-300. PubMed ID: 1693537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
    Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
    Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase of CD57+CD16- cells in long-term survivors of graft-versus-host disease after allogeneic bone marrow transplantation.
    Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1992 Aug; 22(4):238-43. PubMed ID: 1359173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
    Sugita K; Soiffer RJ; Murray C; Schlossman SF; Ritz J; Morimoto C
    Transplantation; 1994 May; 57(10):1465-73. PubMed ID: 7910987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cells in graft-versus-host disease on the rectum: immunopathologic analysis.
    Weisdorf SA; Roy J; Snover D; Platt JL; Weisdorf DJ
    Bone Marrow Transplant; 1991 Apr; 7(4):297-301. PubMed ID: 2070136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flow cytometric analysis of T lymphocyte subsets after human bone marrow transplantation using monoclonal antibodies and dual immunofluorescence].
    Matsue K; Yasue S; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Matsuda T; Harada M
    Nihon Ketsueki Gakkai Zasshi; 1989 May; 52(3):659-64. PubMed ID: 2694718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
    Ericson SG; Colby E; Welch L; Ball ED
    Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
    Charmot D; Ragueneau M; Olive D; Maraninchi D; Mawas C
    Bone Marrow Transplant; 1987 Aug; 2(2):183-94. PubMed ID: 2901879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A.
    Fukuda H; Teshima H; Karasuno T; Hiraoka A; Nakamura H; Masaoka T
    Int J Hematol; 2000 Jan; 71(1):70-4. PubMed ID: 10729997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of peripheral blood CD8/11b cells in bone marrow transplant recipients. III. Subsets of CD8/11b cells differentially regulate immunoglobulin production.
    Lebeck LK; Kaizer H; Gebel HM
    Bone Marrow Transplant; 1992 Jan; 9(1):35-9. PubMed ID: 1371942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation.
    Leino L; Lilius EM; Nikoskelainen J; Pelliniemi TT; Rajamäki A
    Bone Marrow Transplant; 1991 Nov; 8(5):339-44. PubMed ID: 1768967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation.
    Rojas B; Cuhna R; Zafirakis P; Ramirez JM; Lizan-garciía M; Zhao T; Foster CS
    Exp Eye Res; 2005 Sep; 81(3):313-25. PubMed ID: 16129099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
    Soiffer RJ; Ritz J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S7-10. PubMed ID: 8124262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
    Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.